NCT07368582 Real World Pediatric Oncology Rehabilitation in Italy ( ReWori )
| NCT ID | NCT07368582 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Associazione Italiana Ematologia Oncologia Pediatrica |
| Condition | Pediatric Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 249 participants |
| Start Date | 2024-07-19 |
| Primary Completion | 2029-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 249 participants in total. It began in 2024-07-19 with a primary completion date of 2029-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study aims to describe changes in the functional abilities of children, adolescents and young adults with cancer who are undergoing physiotherapy or neuropsychomotor rehabilitation. This is real-world study aiming to describe normal rehabilitation pathways in many different hospitals or rehabilitation centres in Italy. The primary research question is: 1\) What are the longitudinal changes in functional abilities among these patients receiving physiotherapy or neuropsychomotor rehabilitation? The secondary research questions are: 1. What types of rehabilitation practices are implemented across AIEOP centres? 2. What are the rehabilitation needs among patients undergoing physiotherapy or neuropsychomotor rehabilitation? 3. How does health-related quality of life differ across the various stages of the rehabilitation pathway? Participants undergoing usual rehabilitation treatment are evaluated on their functional abilities on a monthly basis. If they agree to participate in this study, the main characteristics of the rehabilitation treatment and the monthly evaluation are collected.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of cancer, * Children, adolescents and young adults aged between 0 and 24 years old, * Children, adolescents and young adults at any stage of treatment and off therapy, * Children, adolescents and young adults referred to the Rehabilitation Service of AIEOP centres and Rehabilitation Centres that provide rehabilitation care for paediatric and young adult cancer patients involved in the study. Exclusion Criteria: * Failure to sign the consent/assent form for participation in the study by the subject and/or by the person exercising parental authority.
Contact & Investigator
Francesca Rossi Rossi, Master's degree
PRINCIPAL INVESTIGATOR
AOU Città della Salute e della Scienza di Torino - Ospedale Infantile Regina Margherita
Frequently Asked Questions
Who can join the NCT07368582 clinical trial?
This trial is open to participants of all sexes, aged 0 Months or older, up to 24 Years, studying Pediatric Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07368582 currently recruiting?
Yes, NCT07368582 is actively recruiting participants. Contact the research team at studiclinici@aieop.org for enrollment information.
Where is the NCT07368582 trial being conducted?
This trial is being conducted at Bergamo, Italy, Bologna, Italy, Bolzano, Italy, Bosisio Parini, Italy and 9 additional locations.
Who is sponsoring the NCT07368582 clinical trial?
NCT07368582 is sponsored by Associazione Italiana Ematologia Oncologia Pediatrica. The principal investigator is Francesca Rossi Rossi, Master's degree at AOU Città della Salute e della Scienza di Torino - Ospedale Infantile Regina Margherita. The trial plans to enroll 249 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.